Sarepta Therapeutics | مبيعات





مبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
BioCryst Pharmaceuticals USD -86.95M 204.03M 2024-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Capricor Therapeutics USD 0 11.13M 2025-03
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Gilead Sciences USD 7.93B 130M 2025-12
Incyte USD 1.51B 140M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Ionis Pharmaceuticals USD 157M 295M 2025-09
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novavax USD 84.51M 330.97M 2024-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12


Sarepta Therapeutics مبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.